Abstract
Muscle twitches and autonomic changes were induced by systemic injections of L-5-hydroxytryptophan (5-HTP) or the serotonin agonist 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in rats previously lesioned with intracranial 5,7-dihydroxytryptamine (5,7-DHT) after desmethylimipramine. Movements were recorded sensitively and continuously by an electronic activity monitor. Spontaneous locomotor activity was strongly reduced after 5-HTP in both intact and lesioned rats, so that electronically recorded activity correlated very closely with disordered jerking movements scored by a behavioral rating scale. This myoclonus was dependent on the doses of 5-HTP and of 5,7-DHT and was strongly inhibited by serotonin antagonists. In lesioned rats, myoclonus occurred with unaltered activity of monoamine oxidase (MAO) and after only small increases in serotonin levels after 5-HTP, but even large increases in availability of serotonin in intact rats, or strong inhibition of serotonin uptake failed to induce myoclonus unless MAO was first inhibited. The response to 5-HTP in lesioned rats was attenuated by repeated injections of 5-HTP or 5-MeO-DMT. This decreased response was in turn blocked by repeated doses of a serotonin antagonist, but appeared not to be due to altered metabolism of 5-HTP or of serotonin; repeated pretreatment with cyproheptadine potentiated the myoclonic response to 5-HTP after DHT. Changes in postsynaptic receptors may be important in the behavioral supersentivity following 5,7-DHT, and restitution of serotonin or stimulation of its receptors after presynaptic denervation may suppress an evolving supersensitivity at receptive postsynaptic membranes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alpert, M., Friedhoff, A. J.: Receptor sensitivity modification in the treatment of tardive dyskinesia. Clin. Pharmacol. Ther. 19, 103–104 (1976)
Baumgarten, H. G., Björkland, A.: Neurotoxins for indoleamine and monoamine neurons. Annu. Rev. Pharmacol. 16, 101–111 (1976)
Baumgarten, H. G., Lachenmayer, L.: 5,7-Dihydroxytryptamine: improvement in chemical lesioning of indoleamine neurons in the mammalian brain. Z. Zellforsch. Mikrosk. Anat. 135, 399–414 (1972)
Christensen, A. V., Fjalland, B., Møller-Nielsen, I.: On the supersensitivity of dopamine receptors, induced by neuroleptics. Psychopharmacology 48, 1–6 (1976)
Costentin, J., Marcais, H., Protais, P., Baudry, M., Delabaume, S., Martres, M. P., Schwartz J. C.: Rapid development of hypersensivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors. Life Sci. 21, 307–314 (1977)
Deguchi, T., Axelrod, J.: Supersensitivity and subsensitivity of the beta-adrenergic receptor in pineal gland regulated by catecholamine transmitter. Proc. Natl. Acad. Sci. U.S.A. 70, 2411–2414 (1973)
Fleming, W., McPhillips, J. J., Westfall, D. P.: Postjunctional supersensitivity and subsensitivity of excitable tissues to drugs. Ergeb. Physiol. Biol. Chem. Exp. Pharmakol. 68, 55–119 (1973)
Friedhoff, A. J., Bonnet, K., Rosengarten, H.: Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa. Res. Commun. Chem. Pathol. Pharmacol. 16, 411–423 (1977)
Friedman, E., Buchweitz, E., Lambert, G.: Sensitivity changes in the central cardiovascular actions of serotonin. Proc. Soc. Neurosci. 3, 249 (1977)
Friedman, M. J., Jaffe, J. H., Sharpless, S. K.: Central nervous system supersensitivity to pilocarpine after withdrawal of chronically administered scopolamine. J. Pharmacol. Exp. Ther. 167, 45–55 (1969)
Gerson, S., Baldessarini, R. J.: Selective destruction of serotonin terminals in rat forebrain by high doses of 5,7-dihydroxytryptamine. Brain Res. 85, 140–145 (1975)
Gerson, S., Baldessarini, R. J., Wheeler, S. C.: Biochemical effects of dihydroxylated tryptamines on central indoleamine neurons. Neuropharmacology 13, 987–1004 (1974)
Jonsson, G., Pollare, T., Hallman, H., Sachs, C.: Developmental plasticity of central serotonin neurons following 5,7-dihydroxytryptamine treatment. In: Serotonin neurotoxins, J. H. Jacoby, L. D. Lytle (eds.). Ann. N. Y. Acad. Sci. 305, 328–345 (1978)
Klawans, H. L., Margolin, D. I., Dana, N., Crosset, P.: Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration. J. Neurol. Sci. 25, 283–289 (1975)
Klawans, H. L., D'Amico, D. J., Nausieda, P. A., Weiner, W. J.: The specificity of neuroleptic- and methysergide-induced behavioral supersensitivity. Psychopharmacology 55, 49–52 (1977)
Maickel, R. P., Miller, F. P.: Fluorescent products formed by reaction of indole derivatives and o-phthaldialdehyde. Analyt. Chem. 38, 1937–1938 (1966)
Marsden, C. D., Tarsy, D., Baldessarini, R. J.: Spontaneous and drug-induced movement disorders in psychotic patients. In: Psychiatric aspects of neurologic disease, D. F. Benson, D. Blumer (eds.), pp. 219–265 New York: Grune and Stratton 1975
Martres, M. P., Costentin, J., Baudry, M., Marcais, H., Protais, P., Schwartz J. C.: Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioral and biochemical studies. Brain Res. 136, 319–337 (1977)
Otsuka, S., Kobayashi, Y.: A radioisotopic assay for monoamine oxidase determination in human plasma. Biochem. Pharmacol. 13, 995–1006 (1964)
Pelz, K., Jirkovsky, I., Adierova, E., Metysova, J., Protiva, M.: Neurotrope und psychotrope Substanzen. XXV. Über die in 8-Stellung durch die methyl-, ter-butylmethoxy-methylthio und methansulfonylgruppe substituierten 10-(4-methylpiperazine) 10,11-dihydrobenzo b,f thiepin-derivate. Collect. Czech. Chem. Commun. 33, 1894–1910 (1968)
Sperk, G., Stewart, R. M., Campbell, A., Baldessarini, R. J.: Inhibition of the development of supersensitivity to serotonin after lesioning with 5,7-dihydroxytryptamine by treatment of mice with cycloheximide. Brain Res. 159, 183–194 (1978)
Stewart, R. M., Growdon, J. H., Cancian, D., Baldessarini, R. J.: 5-Hydroxytryptophan induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat. Neuropharmacology 15, 449–455 (1976)
Tang, L. C., Cotzias, G. C.: L-3,4-Dihydroxyphenylalanine induced hypersensitivity simulating features of denervation. Proc. Natl. Acad. Sci. U.S.A. 74, 2126–2129 (1977)
Tarsy, D., Baldessarini, R. J.: Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13, 927–940 (1974)
Tarsy, D., Baldessarini, R. J.: The tardive dyskinesia syndrome. In: Clinical neuropharmacology, Vol. I, H. Klawans (ed.), pp. 29–61. New York: Raven 1976
Trulson, M. E., Eubanks, E. E., Jacobs, B. L.: Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. J. Pharmacol. Exp. Ther. 198, 23–32 (1976)
Warbritton, J. D., Stewart, R. M., Baldessarini, R. J.: Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat. Brain Res. 143, 373–382 (1978)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stewart, R.M., Campbell, A., Sperk, G. et al. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat. Psychopharmacology 60, 281–289 (1979). https://doi.org/10.1007/BF00426669
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426669